| Original language | English |
|---|---|
| Pages (from-to) | 124-136 |
| Journal | Neuropharmacology |
| Volume | 64 |
| DOIs | |
| Publication status | Published - Jan 2013 |
Keywords
- Phosphodiesterase inhibitors (PDEIs)
- Alzheimer's disease (AD)
- Cognition
- CREB
- BDNF
- APPswe/PS1dE9
Cite this
}
Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. / Sierksma, Annerieke S. R.; Rutten, Kris; Sydlik, Sebastian; Rostamian, Somayeh; Steinbusch, Harry W. M.; van den Hove, Daniel L. A.; Prickaerts, Jos.
In: Neuropharmacology, Vol. 64, 01.2013, p. 124-136.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease
AU - Sierksma, Annerieke S. R.
AU - Rutten, Kris
AU - Sydlik, Sebastian
AU - Rostamian, Somayeh
AU - Steinbusch, Harry W. M.
AU - van den Hove, Daniel L. A.
AU - Prickaerts, Jos
PY - 2013/1
Y1 - 2013/1
KW - Phosphodiesterase inhibitors (PDEIs)
KW - Alzheimer's disease (AD)
KW - Cognition
KW - CREB
KW - BDNF
KW - APPswe/PS1dE9
U2 - 10.1016/j.neuropharm.2012.06.048
DO - 10.1016/j.neuropharm.2012.06.048
M3 - Article
VL - 64
SP - 124
EP - 136
JO - Neuropharmacology
JF - Neuropharmacology
SN - 0028-3908
ER -